Deze pagina is beschikbaar is meerdere talen
Select Language

Alle Bell- en Gongceremonies

  • Arctic Bioscience admitted to trading

     |  Oslo

    17212622db21957-4bdb-4343-b819-78d8de9e47db

    Arctic Bioscience admitted to trading

    Arctic Bioscience admitted to trading on Euronext Growth Oslo 24 February 2021.

    Arctic Bioscience admitted to trading
    Oslo
  • CM.com – 1-jaar beursgenoteerd

     |  Amsterdam

    1721218bb009eac-0160-4a32-a239-0bd4ca944d3e

    CM.com – 1-jaar beursgenoteerd

    CM.com is 1 jaar genoteerd op Euronext Amsterdam. Om dit bijzondere moment te vieren luidde Gilbert Gooijers, COO van CM.com, vanochtend de gong. Hij werd vergezeld door onder andere René van Vlerken, Hoofd Listing van Euronext Amsterdam. CM.com noteerde vorig jaar succesvol aan de Amsterdamse beurs door middel van een fusie met de Special Purpose Acquisition Company (SPAC) Dutch Star Companies One. Het was de eerste SPAC-notering bij Euronext Amsterdam.

    CM.com – 1-jaar beursgenoteerd CM.com
    Amsterdam
  • Skandia GreenPower admitted to trading

     |  Oslo

    1721217c5836740-9d59-4ced-a315-15570391da3f

    Skandia GreenPower admitted to trading

    Skandia GreenPower admitted to trading on Euronext Growth Oslo 22 February 2021.

    Skandia GreenPower admitted to trading
    Oslo
  • Otovo admitted to trading

     |  Oslo

    1721213abb06add-290c-4b1c-afc3-d1fd5051ebf1

    Otovo admitted to trading

    Otovo admitted to trading on Euronext Growth Oslo 19 February 2021.

    Otovo admitted to trading
    Oslo
  • Arctic Fish admitted to trading

     |  Oslo

    1721212b3798b74-b425-476f-81e7-5eb572e1344d

    Arctic Fish admitted to trading

    Arctic Fish admitted to trading on Euronext Growth Oslo 19 February 2021.

    Arctic Fish admitted to trading
    Oslo
  • Envipco admitted to trading

     |  Oslo

    1721204d4fad112-7a88-4567-a529-4920670fd8e5

    Envipco admitted to trading

    Envipco admitted to trading on Euronext Growth Oslo 18 February 2021.

    Envipco admitted to trading
    Oslo
  • Sonans admitted to trading

     |  Oslo

    172119452a4c293-e1c4-42f2-a50b-992d93cf0a27

    Sonans admitted to trading

    Sonans admitted to trading on Euronext Growth Oslo 17 February 2021.

    Sonans admitted to trading
    Oslo
  • Technip Energies lists on Euronext Paris

     |  Paris

    1721189b326e721-3f3d-4d89-b2ed-d3a2c84051d5

    Technip Energies lists on Euronext Paris

    Arnaud Pieton , Chief Executive Officer of Technip Energies , opens the trading day in Paris.

    Created from the spin-off from TechnipFMC plc group in 2021, Technip Energies N.V. is an Engineering and Technology company specialized in providing projects, technologies, products and services on energy infrastructure both onshore and offshore (LNG, downstream, sustainable chemistry, hydrogen, CO2 management and marine infrastructure).

    Technip Energies lists on Euronext Paris
    Paris
  • Pryme admitted to trading

     |  Oslo

    17211860a36f2b0-4612-416a-a15e-7ec1d66e3c54

    Pryme admitted to trading

    Pryme admitted to trading on Euronext Growth Oslo 16 February 2021.

    Pryme admitted to trading
    Oslo
  • Huddly admitted to trading

     |  Oslo

    17211859da27dd2-8a26-41ab-ad31-31beb57ffa44

    Huddly admitted to trading

    Huddly admitted to trading on Euronext Growth Oslo 16 February 2021.

    Huddly admitted to trading
    Oslo
  • Rize ETF – ETFs Listings

     |  Amsterdam

    17211846a60565d-72b6-4a27-b1a0-e3c7786e2aeb

    Rize ETF – ETFs Listings

    Rize ETF viert dat zij vandaag drie ETF’s noteren op Euronext. Jason Kennard, mede-oprichter van Rize ETF, luidde daarom op afstand de gong. Dit deed hij in het bijzijn van onder meer Thomas Weber, ETFs Manager Bedrijfsontwikkeling bij Euronext. De 3 genoteerde ETFs zijn Cybersecurity, Edtech en Sustainable food.

    Rize ETF – ETFs Listings Rize ETF – ETFs Listings
    Amsterdam
  • ESG Core Investments – SPAC Listing en eerste handelsdag

     |  Amsterdam

    172117958e26566-938f-4fe0-b01a-4dcb55e2135a

    ESG Core Investments – SPAC Listing en eerste handelsdag

    Hans Slootweg, Managing Director van ESG Core Investments, werd verwelkomd door Simone Huis in ’t Veld, CEO van Euronext Amsterdam. Van Roij luidde de gong naar aanleiding van de notering van ESG Core Investments, een Special Purpose Acquistion Company (SPAC) met een sterke focus op Environment, Social and Governance (ESG). Het is de eerste SPAC-listing op Euronext van dit jaar.

    ESG Core Investments – SPAC Listing en eerste handelsdag SPAC-listing ESG Core Investments
    Amsterdam
  • Beaconsmind lists on Euronext Access+ Paris

     |  Paris

    17211767f0031f7-1e9c-461e-9d4c-faf7dc8f7cf3

    Beaconsmind lists on Euronext Access+ Paris

    Max Weiland , CEO and Founder, of Beaconsmind , open the trading day in Paris.

    Beaconsmind AG specializes in the development of location-based marketing software solutions for retailers. The group allows retailers to carry out marketing campaigns to increase customer loyalty, revenue and sales at the point of sale and in online.

    Beaconsmind lists on Euronext Access+ Paris
    Paris
  • Medesis Pharma lists on Euronext Growth Paris

     |  Paris

    17211757c955456-40eb-4b72-b703-6cf3dea0ff06

    Medesis Pharma lists on Euronext Growth Paris

    Jean-Claude Maurel , CEO and Founder of Medesis Pharma, opens the trading day in Paris.

    Medesis Pharma S.A. is specialized in the research and development, based on a breakthrough technology (AONYS®) for the delivery of therapeutic molecules, of drugs to treat diseases for which there is no effective treatment.

    The company's portfolio includes two candidates in the fields of neurodegenerative diseases (Alzheimer's disease and Huntington's disease), two candidates for antiviral treatments to respond to the health emergency towards the treatment of COVID-19 at different stages (one for hospitalized patients in acute respiratory distress, and another for early treatment in urban medicine), and 2 candidates to treat contaminated populations after a civil or military nuclear accident (Plutonium decorporation and cesium decorporation).

    Medesis Pharma lists on Euronext Growth Paris
    Paris
  • UBS Asset Management

     |  Amsterdam

    1721171e01215ac-2613-45ac-9343-4eba8092f65a

    UBS Asset Management – 20 jaar ETFs

    UBS Asset Management vierde vandaag dat zij al twintig jaar ETFs aanbieden. Marcel Danen, Executive Director van UBS, luidde daarom op afstand de gong, in het bijzijn van onder meer Brieuc Louchard, verantwoordelijk voor ETFs binnen Euronext. Tien jaar geleden lanceerde het bedrijf haar eerste duurzame ETF en sinds vijf jaar zijn verschillende ETFs genoteerd aan de Amsterdamse beurs.

    UBS Asset Management UBS - 20 years ETF
    Amsterdam
  • Hydrogen Refueling Solutions

     |  Paris

    1721168e6f2aa11-7c06-43e0-8e73-bfcfe11319ac

    Hydrogen Refueling Solutions lists on Euronext Growth Paris

    Hassen Rachedi , CEO and Founder, Philippe Bottu, General Manager, and Olivier Dhez, Business Development & Marketing Director of Hydrogen Refueling Solutions , open the trading day in Paris.

    Hydrogen Refueling Solutions is specialized in the mass production of turnkey hydrogen refueling stations with large capacities (100 kg to 1 ton) for heavy vehicles (transport, buses, garbage trucks, etc.) and passenger vehicles.

    At the end of 2020, the group has a production site located in France.

    Hydrogen Refueling Solutions HRS
    Paris
  • Cambi admitted to trading

     |  Oslo

    1721166c236457f-5af3-4b48-8ac2-6cb07813c16a

    Cambi admitted to trading

    Cambi admitted to trading on Euronext Growth Oslo 9 February 2021.

    Cambi admitted to trading
    Oslo
  • Pherecydes Pharma lists on Euronext Growth Paris

     |  Paris

    172115949f396c4-4243-44b5-a6bb-c3217c8b6b65

    Pherecydes Pharma lists on Euronext Growth Paris

    Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, opens the trading day in Paris.

    Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

    Pherecydes Pharma lists on Euronext Growth Paris Pherecydes Pharma lists on Euronext Growth Paris
    Paris